SCHEMBL22189073

SCHEMBL22189073

CCCCCCCCCCCCn1cc[n+](C)c1C(=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
HSP90AA1 P07900 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
APAF1 O14727 1/20 0.41
NPC1 O15118 1/20 0.41
PLA2G1B P04054 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
EEF2K O00418 2/20 0.39
EEF2 P13639 2/20 0.39
PLK4 O00444 1/20 0.39
JAK2 O60674 1/20 0.39
EGFR P00533 1/20 0.39
TYK2 P29597 1/20 0.39
FLT3 P36888 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21049641 1.00 MEN1 (0.41) MEN1KMT2AHSP90AA1SMN1; SMN2APAF1
SCHEMBL21049626 1.00 MEN1 (0.41) MEN1KMT2AHSP90AA1SMN1; SMN2APAF1
SCHEMBL21049594 1.00 MEN1 (0.41) MEN1KMT2AHSP90AA1SMN1; SMN2APAF1
SCHEMBL21049629 1.00 MEN1 (0.41) MEN1KMT2AHSP90AA1SMN1; SMN2APAF1
SCHEMBL21049536 1.00 MEN1 (0.41) MEN1KMT2AHSP90AA1SMN1; SMN2APAF1
SCHEMBL21049572 0.98 MEN1 (0.38) MEN1KMT2AHSP90AA1SMN1; SMN2APAF1
SCHEMBL1095619 0.94 FDPS (0.35) MEN1KMT2AHSP90AA1SMN1; SMN2APAF1
SCHEMBL21049622 0.87 FDPS (0.32) SMN1; SMN2HTTFDPS
SCHEMBL22188990 0.82 CA1 (0.52) MEN1KMT2AHSP90AA1SMN1; SMN2APAF1
SCHEMBL22188947 0.82 CA1 (0.52) MEN1KMT2AHSP90AA1SMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295368-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT KOEI CHEMICAL COMPANY, LIMITED (JP) 2023-09-21 US disclosed
US-11718704-B2 Catalyst for dissociation of blocking agent for blocked isocyanates, and thermosetting composition containing said catalyst for dissociation of blocking agent KOEI CHEMICAL COMPANY, LIMITED (JP) 2023-08-08 US disclosed
CN-111094375-B Blocking agent dissociation catalyst for blocked isocyanate and thermosetting composition containing the same 广荣化学株式会社 2022-04-01 CN disclosed
EP-3689931-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT Koei Chemical Company, Limited (JP) 2020-08-05 EP disclosed
US-20200216600-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT KOEI CHEMICAL COMPANY, LIMITED (JP) 2020-07-09 US disclosed
CN-111094375-A Blocking agent dissociation catalyst for blocked isocyanate and thermosetting composition containing the same 广荣化学工业株式会社 2020-05-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295368-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT IDH3A, RCOR1, MUS81 MEN1 176/4885KMT2A 236/4885HSP90AA1 1174/4885
US-11718704-B2 Catalyst for dissociation of blocking agent for blocked isocyanates, and thermosetting composition containing said catalyst for dissociation of blocking agent IDH3A, RCOR1, MUS81 MEN1 176/4885KMT2A 236/4885HSP90AA1 1174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.